checkAd

     113  0 Kommentare Liminal BioSciences to Report Fourth Quarter and Year Ended 2022 Financial Results on March 15, 2023 - Seite 2

    Corporate Contact: Shrinal Inamdar, Associate Director, Investor Relations and Communications,  s.inamdar@liminalbiosciences.com, +1 450.781.0115; Media Contact, Kaitlin Gallagher, kgallagher@berrypr.com, +1 212.253.8881

    Lesen Sie auch

    Cision View original content:https://www.prnewswire.co.uk/news-releases/liminal-biosciences-to-report-fourth-quarter-and-year-ended-2022-financial-results-on-march-15-2023-301770641.html


    The Liminal BioSciences Stock at the time of publication of the news with a fall of -1,78 % to 5,427USD on Nasdaq stock exchange (13. März 2023, 19:00 Uhr).

    PR Newswire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 2 von 2

    Verfasst von PR Newswire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Liminal BioSciences to Report Fourth Quarter and Year Ended 2022 Financial Results on March 15, 2023 - Seite 2 LAVAL, QC, and CAMBRIDGE, England, March 13, 2023 /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), today announced that it plans to report its fourth quarter and year ended 2022 financial results after …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer